SURGICAL EXPERIENCE WITH PORTAL HYPERTENSION DUE TO HEPATOPORTAL SCLEROSIS (NONCIRRHOTIC PORTAL FIBROSIS)

Authors

  • MOHAMMADJAFAR FARAHVASH
  • SIRUS VAKILI From The Department Of Surgery And Medicine, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
Abstract:

Hepatoportal sclerosis or idiopathic portal hypertension has a worldwide distribution with prevalence in developing and temperate countries. Of 64 patients with this disease seen during a twelve year period, 36 underwent splenectomy or a shunt procedure. The indications for surgical intervention were severe hypersplenism and persistent left upper abdominal pain andlorhistory of frequent episodes of esophageal bleeding. There were two operative deaths from uncontrollable bleeding. Of 34 patients, none developed esophageal bleeding or encephalopathy on follow-ups ranging from one to 12 years. Splenectomy in patients without bleeding was effective. Proximal splenorenal shunt was also satisfactory in all cases. However, in the last few cases, Warren's shunt has produced even more encouraging results. In addition to a general overview, features of this disease not previously discussed or emphasized in the literature, operative findings and surgical methods used, along with long-term results, are presented.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

surgical experience with portal hypertension due to hepatoportal sclerosis (noncirrhotic portal fibrosis)

hepatoportal sclerosis or idiopathic portal hypertension has a worldwide distribution with prevalence in developing and temperate countries. of 64 patients with this disease seen during a twelve year period, 36 underwent splenectomy or a shunt procedure. the indications for surgical intervention were severe hypersplenism and persistent left upper abdominal pain andlorhistory of frequent episode...

full text

Noncirrhotic Portal Hypertension due to Nodular Regenerative Hyperplasia Treated with Surgical Portacaval Shunt

Nodular regenerative hyperplasia (NRH) is an uncommon condition, but an important cause of noncirrhotic intrahepatic portal hypertension (NCIPH), characterized by micronodules of regenerative hepatocytes throughout the liver without intervening fibrous septae. Herein, we present a case of a thirty-seven-year-old female with systemic lupus erythematosus (SLE) who was discovered to have significa...

full text

Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

The Asian Pacific Association for the Study of the Liver (APASL) Working Party on Portal Hypertension has developed consensus guidelines on the disease profile, diagnosis, and management of noncirrhotic portal fibrosis and idiopathic portal hypertension. The consensus statements, prepared and deliberated at length by the experts in this field, were presented at the annual meeting of the APASL a...

full text

Idiopathic noncirrhotic portal hypertension: current perspectives

The term idiopathic noncirrhotic portal hypertension (INCPH) has been recently proposed to replace terms, such as hepatoportal sclerosis, idiopathic portal hypertension, incomplete septal cirrhosis, and nodular regenerative hyperplasia, used to describe patients with a hepatic presinusoidal cause of portal hypertension of unknown etiology, characterized by features of portal hypertension (esoph...

full text

Hepatoportal sclerosis: a cause of portal hypertension to bear in mind.

To the editor: Hepatoportal sclerosis (HS) is an idiopathic noncirrhotic intrahepatic portal hypertension characterized by splenomegaly, hypersplenism and portal hypertension. Although it is considered uncommon in developed countries there is an increasing number of cases reported which could traduce a better knowledge of this disease and a higher level of suspicion. Our objective is to report ...

full text

Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma

Background. The purpose of this study was to evaluate the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) placement in the management of portal hypertension in noncirrhotic patients with portal cavernoma. Methods. We conducted a single institution retrospective analysis of 15 noncirrhotic patients with portal cavernoma treated with TIPS placement. 15 patients (4 wome...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 1  issue 1

pages  50- 54

publication date 1987-11

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023